1 / 53

Myopathy

Myopathy. Primary Muscle Disease Functional Structural. Lower vs. Upper Motor Neuron Weakness. *Disuse atrophy can develop after initial presentation. Distinguishing Lower Motor Weakness from Muscle Weakness. Weakness due to neuropathy: lower motor neuron disease.

Download Presentation

Myopathy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Myopathy • Primary Muscle Disease • Functional • Structural

  2. Lower vs. UpperMotor Neuron Weakness *Disuse atrophy can develop after initial presentation

  3. Distinguishing Lower Motor Weakness from Muscle Weakness • Weakness due to neuropathy: lower motor neuron disease. • Weakness due to myopathy: nerve function intact.

  4. Symptoms of Muscle Disease • Negative • Weakness • Proximal and symmetric • Waddling gait; difficulty of rising from sitting, climbing stairs; getting up from a squatted position, Gower’s sign • Fatigue; exercise intolerance • Metabolic, mitochondrial • Atrophy • Positive • Myalgia • Cramp • Contractures • Increased lordosis, scoliosis • Myotonia • Impaired relaxation of muscle after forceful voluntary contraction • Due to repetitive depolarization of the muscle membrane • Myoglobinuria • Dark colored urine • Excessive release of myoglobin from muscle • Metabolic-toxic-idiopathic • Pseudohypertrophy • Tendon reflexes are normal or depressed from A Kornberg MD

  5. Gower’s Sign

  6. Key questions • Constant or episodic symptoms • Age at onset • Is there a family history • Acute,subacute, chronic • Life long • Congenital • Progressive or non-progressive • Proximal-distal symptoms • Cranial involvement • Triggering factors • Exercise • Carbonhydrate • Relieved by exercise • Systemic signs • Rash, dark/red urine, cardiac, cataract, neuropathy, mental retardation

  7. Differential Diagnosis Lab • CK • Electrolytes • Serum myoglobin • Serum kreatinin, BUN • Complete Blood Count • ESR • Thyroid function tests • AST • Urinalysis • Myoglobinuria

  8. Diagnosis of muscle diseases • Creatinine kinase levels increased in many myopathies • sign of muscle fiber necrosis • ENG / EMG: differentiation between neurogenic and myogenic weakness • Muscle biopsy: signs of muscle fiber abnormality, inflammation, immunostaining of muscle constituents • Genetic testing • EKG-Echocardiography

  9. Classification of Myopathies • Hereditary muscle diseases • Muscle dystrophies • Myotonias and Channelopathies • Congenital Myopathies • Metabolic myopathies • Mitochondrial myopathies • Acquired muscle diseases • Inflammatory myopathies • Idiopathic, infectious • Endocrine myopathies • Myopathies associated with other systemic illness • Drug induced/toxic myopathies

  10. Muscular Dystrophies • Hereditary • Progressive • Pseudohypertrophy +++ • Muscles replaced by fat • Very High CK • Genetic defect of proteins constituting the sarcolemma-associated cytoskeleton system • Dystrophinopathies and others

  11. Muscular Dystrophies • Dystrophinopaties • Duchenne, Becker • Limb Girdle dystrophies • Fascioscapulohumeral dystrophy • Oculopharyngeal dystrophy • Distal muscular dystrophies • Myotonic dystrophies

  12. Muscular Dystrophies-Duchenne • X linked recessive • Absence of dystrophinprotein • Slow to reach motor milestones • Symptoms by age 5 • All walk, may never run • End up in wheelchair by age 12 • Frequently mildly mentally retarded • Life expectancy < 20 years with death related to respiratory failure or cardiomyopathy • Dx- Genetic, muscle biopsy

  13. Duchenne muscular dystrophy Normal Duchenne dystrophy • Diagnosis: • Lack of immunostaining of dystrophin in muscle biopsy specimen • Demonstration of deletion in the dystrophin gene

  14. Muscular Dystrophies-Becker • Less common than Duchenne • X-linked recessive • Later Onset • 10 years • Most patients ambulant until 3rd-4th decade • Death from heart failure due to dilated cardiomyopathy-late 40’s • Mental retardation is rare

  15. Management of DMD/BMD • Annual echocardiography • Cardiomyopathy • ACE inhibitor and/or beta blocker....digoxin • Cardiomyopathy and decreased pulmonary function + • Pneumoccal vaccine • Annual influenza vaccine • Anesthesia complications...... • Consider TIVA • Susceptibility to malign hyperthermia • Rhabdomyolisis, hyperkalemia, cardiac arrest • Succinylcholine, halothane, isoflurane, sevoflurane • Reaction to inhaled anesthetics, muscle relaxants, hypoventilation, atelectasis, cardiac arrhytmias, heart failure, difficulty weaning from mechanical ventilation,

  16. Management of DMD/BMD • Low dose daily prednol - deflazacort in DMD • İncrease of muscle strength-maximum at 3 months • Prolongs independent ambulation • İmprovement of FVC • Preserves cardiac function • Increases osteoporosis • AAN recommendations • Prednol 0,75 mg/kg/day for patients over the age of 5 years • Watch for weight gain, cushingoid appearance, fractures, gastrointestinal symptoms..... • Decrease to 0,5 then 0,3 mg/kg/day if weight gain occurs • Deflazacort 0,9 mg/kg/day • Watch for weight gain and cataracts

  17. Management of DMD/BMD • Vitamin D supplement • If serum vitamin D level less than 20ng/ml • Nutritionist • Avoid obesity • Physical Therapy, orthopedic devices • Gene Therapy • Aminoglycosides, PTC124, Creatine

  18. Facioscapulohumeral dystrophy • Prevalence: 1 in 20,000 • Most common after DMD and BMD • Autosomal dominant • Age of onset: before 20 • Sensorineural hearing loss

  19. Facioscapulohumeral dystrophy • myopathic face, • İnability to smile, whistle or close eyes • Life span is not significantly affected Charcot

  20. Facioscapulohumeral dystrophy • Progressive muscular weakness and atrophy involving the face, scapular, proximal arm and peroneal muscles winging of the scapula

  21. Oculopharyngeal Muscular Dystrophy • 5’th-6’th decade • Extraocular muscle weakness • Ptosis • Dysphagia • Later facial and proximal muscle weakness • Autosomal Dominant

  22. Emery Dreifuss Muscular DystrophyEDMD • Childhood- adolescence • Slowly progressive • Contractures before weakness • Neck extansors, elbows, ankles • Cardiomyopathy • Atrial arrhythmias and syncope From: A Kornberg Emery-Dreifuss: Rigid spine

  23. Limb-girdle dystrophies • Autosomal Dominant (10%) • LGMD-1 • Autosomal Recessive (90%) • LGMD-2 • Symptoms between 2-40 • High CK • Slow progressive proximal muscle weakness • Onset variable • Spares the face

  24. Limb-girdle dystrophies • Causes: • Sarcoglycanopathies • α, β, γ, δ sarcoglycans • Clinically often indistinguishable from Duchenne-dystrophy • scapular winging more pronounced, hamstrings and quadriceps equally affected • Calpain - 3 mutation • Dysferlin deficiency etc. • Caveolin deficiency (AD)

  25. Sarcoglycanopathies Sarcoglycanopathy Normal

  26. Myotonic dystrophy • Prevalence: 1 in 8000 • Cause: CTG repeat expansion in a gene on chr. 19 • Autosomal dominant inheritance, with anticipation • Multisystemic disease: • Myotonia: hyperexcitability of muscle membrane  inability of quick muscle relaxation • Progressive muscular weakness and wasting, most prominent in cranial and distal muscles • Cataracts, frontal balding, testicular atrophy • Cardiac abnormalities, mental retardation, endocrinopathy

  27. Myotonic dystrophy

  28. Myotonic dystrophy

  29. Muscle channelopathies

  30. Periodic paralysis • Characterized by episodes of flaccid muscle weakness occurring at irregular intervals • Strength is normal between attacks • General characteristics : • Hereditary; • Most are associated with alteration in serum potassium levels; • Hypokalemic, hyperkalemic, normokalemic • Myotonia sometimes coexists; • Both myotonia and PP result from defective ion channels.

  31. Periodic paralysis • The physiologic basis of flaccid weakness is inexcitability of the muscle membrane • (ie, sarcolemma).

  32. Myotonia congenita • Mutation in the muscle Cl gene • Autosomal dominant • Thomsen • Autosomal recessive • Becker • Symptoms: • Myotonia (hyperexcitability of the muscle membrane): muscle stiffness and abnormal muscle relaxation, warm-up phenomenon • Hypertrophied muscles • Therapy: phenytoin, mexiletin

  33. Myotonia congenita

  34. Thyrotoxic periodic paralyses • Common in adults aged 20-40 years. • Hyperinsulinemia, a carbohydrate load, and exercise are important in precipitating paralytic attacks. • Attacks last hours to days.

  35. Congenital Myopathies • Age of onset in childhood • Occasionally adults • Familial • Occasionally sporadic • Floppy infant • Hypotonia, muscle weakness • Structered • Central core disease • Multi-minicore disease • Myotubular and centronuclear myopathies • X-linked myotubular myopathy • Centronuclear myopathy • Nemaline myopathy • Actin aggregate myopathy • Desminopathy • Crystallinopathy • Hyaline body myopathy • Unstructured • Congenital fiber type disproportion

  36. Metabolic Myopathies Failed Energy Production • Classification of metabolic myopathies • Carbonhydrate processing disorders • Fat-processing disorders • Mitochondrial disorders

  37. Metabolic Myopathies • Dynamic rather then static symptoms • Cramps, pain, exercise intolerance rather than fixed symptoms • A history of weakness, pain and/or myoglobinuria provoked by short duration high intensity exercise, • Lifting heavy weight, swimming, climbing stairs, running • Exercise intolerance and myoglobinuria • Glycolytic pathway defect • Episodic weakness in association with fever, after prolonged mild exercise or prolonged fasting • After 1 hour • Walking • Lipid metabolism defects

  38. Metabolic Myopathies Laboratory • Urinary • Ketons • Myoglobin • Dicarboxylic acids • Acylglycins • Serum • Lactate • Pyruvate • Lactic acid dehydrogenase • Uric acid • Free and total carnitine • Ketones • Glucose • Ammonia • Myoglobin • Liver transaminases • Potassium, calcium, phosphate • Creatinine • Acylcarnitine CK at rest and during an episode

  39. Mitochondrial Myopathies • Mitochondria • Main source of metabolic energy

  40. Mitochondrial Myopathies • Nuclear DNA defects • Leigh, MNGIE, MDS • Mitochondrial DNA defects

  41. Idiopathic Inflammatory Myopathies • Clinical Classification • Polymyositis (PM) • Dermatomyositis (DM) • Inclusion Body Myositis (IBM) • Juvenile Dermatomyositis • Myositis associated with malignancy • Myositis associated with collagen vascular disease Bohan & Peter (1975). NEJM. Tanimoto et al. (1995). J Rheumatology.

  42. Polymyositis / Dermatomyositis • Diagnostic criteria • Proximal muscle weakness • Elevated serum CK • Myopathic changes on EMG • Muscle biopsy demonstrating lymphocytic inflammation • Dermatomyositis: Skin rash as well as criteria above • Definitive diagnosis with four criteria having been met Bohan & Peter (1975). NEJM.

  43. Polymyositis-Dermatomyositis • Painful muscles (60%) • Polymyositis: • Cell-mediated immune response against muscle fibers • Less often paraneoplastic than DM • Cardiac abnormalities • Dermatomyositis: • Humorally mediated autoimmune microangiopathy affecting the muscles and skin • Rash on the face, neck • Periorbital oedema • Dysphagia • Cardiac abnormalities, interstitial lung disease • May be paraneoplastic

  44. Dermatomyositis

  45. Treatment for DM, PM • Immunosuppression • long-term treatment with corticosteroids (1 mg/day) • Mtx-Imuran...

  46. Inclusion Body Myositis • Mainly affects older males • Symptoms begin insidiously and progress slowly • Symptoms are often present 5-6 years before diagnosis • Finger flexors-quadriceps • May include focal, distal or asymmetric weakness • Neurogenic or mixed neurogenic / myopathic changes on EMG • Dysphagia is noted in more than 20% of patient Wortmann RL. Primer on Rheum Dis. 12th edition. 2001:369–376.

  47. Dermatomyositis B cells, macrophages CD4 T cells Decreased capillaries Perifascicular atrophy Perivascular infiltrate Polymyositis Mononuclear cells CD8 T cells Endomysial infiltrate Myonecrosis Patchy, focal Muscle Biopsy:Histology and Immunochemistry • IBM • Same as PM; also: • Rimmed vacuoles • Eosinophilic cytoplasmic inclusions Rolak LA. Neurology Secrets. 2005: 63-7.

  48. Infectious causes of myopathy • Trichinosis • Cysticercosis • Toxoplasmosis • HIV • Coxsackie A and B • Influenza • Lyme • Staphylococcus aeurus

  49. Endocrine myopathies • Endocrine myopathies • Thyrotoxic myopathy • Hypothyroidism • Hyperparathyroidism • Adrenal insufficiency • Hypokalemia

More Related